Literature DB >> 34282192

Implication of FDG-PET/CT without synchronous colonic lesion in patients with stenotic left-sided colorectal cancer.

Jong Il Lee1, Sang Sik Cho1, Ui Sup Shin2, Byong Ho Jeon1, Sun Mi Moon1, Younjoo Kim3, Ki Young Yang3, Byung Il Kim4.   

Abstract

Although 18-fluoro-2-deoxy-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) is useful for detecting synchronous colorectal cancer (CRC) in stenotic CRC, long-term outcomes of patients without synchronous FDG-avid lesions are not well reported. We investigated postoperative colonoscopy results in patients with left-sided stenosing CRC without synchronous FDG-avid lesions. In this retrospective review, 754 patients with left-sided CRC without synchronous FDG-avid lesions on preoperative 18F-FDG PET/CT were divided into two groups based on the completeness of preoperative colonoscopy. Propensity score matching was performed to balance baseline characteristics. Results of postoperative colonoscopy were compared in both the unmatched and matched cohorts. At 1 and 5 years after surgery, the cumulative risk of advanced adenoma (AA) or carcinoma (CA) in all patients, risk of CA, and additional surgical risk were 1.8% and 10.1%, 0.1% and 0.4%, and 0% and 0.5%, respectively. In both cohorts, the AA risk was significantly higher in the incomplete colonoscopy group. However, the risk of CA showed no between-group difference in the matched cohort. Additional surgical risk did not differ between the two groups. Thus, the finding of negative FDG-avid lesions in the proximal colon in addition to the target CRC ensures the absence of additional lesions warranting surgical plan changes.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34282192     DOI: 10.1038/s41598-021-94030-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  4 in total

1.  Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.

Authors:  Jordi Fuertes; Clara Montagut; Santi Bullich; Mar Iglesias Coma; Antoni Mestre-Fusco; Marina Suárez-Piñera; Carlos Trampal; Joaquim Bellmunt
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2014-09-26       Impact factor: 1.359

2.  FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

Authors:  K L Berger; S A Nicholson; F Dehdashti; B A Siegel
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

3.  Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.

Authors:  Zoya Rabkin; Ora Israel; Zohar Keidar
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

4.  Usefulness of (18)F-FDG PET/CT to Detect Metastatic Mucinous Adenocarcinoma Within an Inguinal Hernia.

Authors:  Hyo Jung Seo; Byung Wook Min; Jae Seon Eo; Sun Il Lee; Sang Hee Kang; Sung Yup Jung; Sang Chul Oh; Jae Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2015-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.